For consumers who are injured by a drug or medical device, the first question that arises is often a simple one. They want to know how a product that was approved by the FDA could do them serious harm. The simple answer is that Food and Drug Administration (FDA) approval of a drug or device […]
Andrus Wagstaff Law Blog
Risperidal was the world’s first medication approved for treating autism in children, and it’s still the most widely prescribed. Upon initial release, it seemed like a miracle drug. Unquestionably, it effectively manages many of the behavioral difficulties associated with autism. The drug is also used in the treatment of schizophrenia and bipolar disorder. But for […]
Nobody likes an upper respiratory infection. Bacterial infections of any kind can be extremely serious and require medical attention. But what happens when the medicine your doctor prescribes solves one problem while causing another? We now know that fluoroquinolone antibiotics, which are commonly prescribed to treat upper respiratory infections and other bacterial infections, may directly […]
Is Zofran Dangerous? Understanding Pregnancy & Zofran Injury Zofran is a popular prescription medication that has been in use in the United States since 1992, when the FDA first approved it for treatment of cancer patients. Specifically, Zofran helps to prevent nausea and vomiting caused by chemotherapy. But in recent years, it’s become increasingly popular […]
Here at Andrus Wagstaff, PC, we help people who’ve suffered injury as a result of dangerous drugs or defective products. Headquartered in Denver, we represent personal injury victims all across the country and fight for financial compensation on their behalf. We are a national mass tort law firm. You might be wondering what “mass tort” […]
The Food and Drug Administration (FDA) recently announced that a medical product safety monitoring pilot program launched in 2009 is set to become a full-time system. According to a blog post written by Dr. Janet Woodcock, Director of the FDA Center for Drug Evaluation, the Mini-Sentinel program, which uses a scientific technique called “active surveillance,” […]
The FDA says that laparoscopic power morcellators—surgical devices commonly used to remove fibroid tumors from the uterus or the entire uterus—should not be used to perform these procedures in the vast majority of women because they can spread unsuspected cancer. The FDA’s Immediately in Effect (IIE) guidance, issued November 24, updates a safety communication issued […]
The results of preliminary lawsuits against transvaginal mesh manufacturers seems to indicate that the legal tide is turning in favor of women who claim that the devices cause injuries such as pain, bleeding and infection. Seven mesh device makers, including Boston Scientific, Johnson & Johnson, C.R. Bard and Endo International, are facing thousands of lawsuits […]
Pharmaceutical companies drive demand for their drugs through direct-to-consumer advertising on television, the Internet, the radio and in print. An AARP poll found that 90% of Americans have seen or heard one such advertisement, most commonly on television. In fact, a study published in the Annals of Family Medicine notes that Americans see as many […]
$3 billion: that’s how much GlaxoSmithKline agreed to pay the U.S. Department of Justice in 2012 to settle civil and criminal charges related to its misbranding of the drugs Paxil and Wellbutrin and its failure to disclose safety information about the diabetes drug Avandia. Although the $3 billion fine was the largest fine ever levied […]
